The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMARIN CORP PLC | SPONSORED ADR | 023111404 | 24,197,292 | 1,673,395 | SH | SOLE | 1,673,395 | 0 | 0 | |||
| BIOHAVEN LTD | COM | G1110E107 | 4,764,537 | 563,184 | SH | SOLE | 563,184 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 15,068,542 | 228,623 | SH | SOLE | 228,623 | 0 | 0 | |||
| INNOVIVA INC | COM | 45781M101 | 49,651,135 | 2,130,950 | SH | SOLE | 2,130,950 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 32,252,109 | 9,188,635 | SH | SOLE | 9,188,635 | 0 | 0 | |||
| LANTHEUS HLDGS INC | COM | 516544103 | 12,660,806 | 166,919 | SH | SOLE | 166,919 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 15,352,057 | 116,533 | SH | SOLE | 116,533 | 0 | 0 | |||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 3,237,362 | 4,190 | SH | SOLE | 4,190 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM NEW | 929033207 | 453,118 | 25,399 | SH | SOLE | 25,399 | 0 | 0 | |||